Hydrocortisone Orifarm

Hydrocortisone Orifarm is a topical corticosteroid medication whose active ingredient is hydrocortisone. It is supplied in a topical formulation intended for skin application, though specific strength and dosage form are not disclosed. Classified under the ATC code D07AA02, the product belongs to the corticosteroid drug class and is marketed within the European Union. It works by modulating inflammatory and immune responses in the skin locally and effectively.

Hydrocortisone Orifarm is commonly employed for short‑term relief of mild to moderate inflammatory skin conditions. It is applied to the affected area for a limited duration, typically under medical guidance. - Relief of mild eczema or atopic dermatitis. - Treatment of contact dermatitis caused by irritants or allergens. - Management of minor skin irritations such as insect bites, rashes, or sunburn. - Reduction of inflammation associated with psoriasis plaques when used as adjunct therapy. - Soothing of localized allergic reactions on the skin.

Adverse reactions to Hydrocortisone Orifarm are generally mild when used as directed, but occasional more serious events can occur, especially with prolonged application or use on large body surfaces.

Common: - Skin burning, stinging, or itching at the application site. - Mild erythema or redness. - Dryness or peeling of the treated skin. - Slight swelling or edema. - Hyperpigmentation of the skin. - Transient acneiform eruption.

Serious: - Development of contact dermatitis or allergic reaction. - Skin atrophy or thinning with prolonged use. - Stretch marks (striae) in the treated area. - Secondary bacterial, fungal, or viral infection of the skin. - Hypopigmentation of the skin. - Systemic absorption leading to adrenal suppression (rare). - Delayed wound healing. - Systemic effects such as Cushingoid features (rare).

When considering Hydrocortisone Orifarm, clinicians and patients should observe several precautionary measures to minimize risks and ensure appropriate use. - Avoid application on broken, infected, or ulcerated skin unless directed by a healthcare professional. - Limit use to the prescribed area and duration; prolonged or extensive application can increase systemic absorption. - Do not use under occlusive dressings unless specifically instructed. - Exercise caution in patients with known sensitivity to corticosteroids or other ingredients in the formulation. - Pregnant or breastfeeding individuals should consult a physician before use due to limited safety data. - Children may be more susceptible to systemic effects; use the lowest effective potency and monitor closely.

Hydrocortisone Orifarm may interact with other topical agents or systemic medications that affect skin integrity or cortisol metabolism.

Avoid: - Concurrent use with other potent topical corticosteroids on the same area. - Application together with topical antibiotics that may cause irritation when combined. - Use with skin‑lightening agents that increase percutaneous absorption.

Use with caution: - Systemic glucocorticoids: may augment systemic corticosteroid effects if large skin areas are treated. - Antifungal or antiviral creams: monitor for reduced efficacy or increased irritation. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically: assess for additive local irritation.